MAL2 and bladder transitional cell carcinoma: Gene mutations of predicted target genes (PDCD6, GNG5, PHF6, MAL2, SLC25A15, PTDSS1) in BLCA and their OS and PFS were analyzed by cBioPortal (Figure 10).